1. Home
  2. RZLT vs IPI Comparison

RZLT vs IPI Comparison

Compare RZLT & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • IPI
  • Stock Information
  • Founded
  • RZLT 2010
  • IPI 2000
  • Country
  • RZLT United States
  • IPI United States
  • Employees
  • RZLT N/A
  • IPI N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • RZLT Health Care
  • IPI Industrials
  • Exchange
  • RZLT Nasdaq
  • IPI Nasdaq
  • Market Cap
  • RZLT 819.3M
  • IPI 470.9M
  • IPO Year
  • RZLT N/A
  • IPI 2008
  • Fundamental
  • Price
  • RZLT $9.35
  • IPI $26.18
  • Analyst Decision
  • RZLT Strong Buy
  • IPI Strong Sell
  • Analyst Count
  • RZLT 7
  • IPI 1
  • Target Price
  • RZLT $14.86
  • IPI $23.00
  • AVG Volume (30 Days)
  • RZLT 1.5M
  • IPI 166.5K
  • Earning Date
  • RZLT 11-07-2025
  • IPI 11-05-2025
  • Dividend Yield
  • RZLT N/A
  • IPI N/A
  • EPS Growth
  • RZLT N/A
  • IPI N/A
  • EPS
  • RZLT N/A
  • IPI N/A
  • Revenue
  • RZLT N/A
  • IPI $225,166,000.00
  • Revenue This Year
  • RZLT N/A
  • IPI $10.01
  • Revenue Next Year
  • RZLT N/A
  • IPI N/A
  • P/E Ratio
  • RZLT N/A
  • IPI N/A
  • Revenue Growth
  • RZLT N/A
  • IPI 10.53
  • 52 Week Low
  • RZLT $2.22
  • IPI $20.86
  • 52 Week High
  • RZLT $10.04
  • IPI $39.01
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 55.03
  • IPI 37.27
  • Support Level
  • RZLT $9.00
  • IPI $24.81
  • Resistance Level
  • RZLT $10.03
  • IPI $28.67
  • Average True Range (ATR)
  • RZLT 0.56
  • IPI 0.95
  • MACD
  • RZLT -0.05
  • IPI -0.12
  • Stochastic Oscillator
  • RZLT 55.35
  • IPI 35.52

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Share on Social Networks: